Meta‐analysis: pre‐operative infliximab treatment and short‐term post‐operative complications in patients with ulcerative colitis
The DOI matches its Crossref record.
Abstract
Aliment Pharmacol Ther 31 , 486–492 Summary: Background Infliximab was approved for use in ulcerative colitis in recent years. It has been debated if infliximab increases the risk of post‐operative complications in patients with ulcerative colitis. Aim To perform a meta‐analysis that examines the relationship between preoperative infliximab treatment and short‐term post‐operative complications in patients with ulcerative colitis. Methods We searched the PubMed and MEDLINE databases to identify observational studies on the impact of pre‐operative infliximab use on short‐term post‐operative complications in ulcerative colitis. Infectious complications mainly included wound infection, sepsis and abscess, whereas non‐infectious complications included intestinal obstruction, thromboembolism and gastrointestinal haemorrhage. Pooled odds ratios (ORs) were calculated for each relationship. Results A total of 5 studies and 706 patients were included in our meta‐analysis. Overall, we did not find a strong association between pre‐operative treatment of infliximab and short‐term infectious [OR 2.24, 95% confidence interval (CI) 0.63–7.95] or non‐infectious (OR 0.85, 95% CI 0.50–1.45) post‐operative complications in ulcerative colitis patients. On the contrary, we discovered that pre‐operative infliximab use increased short‐term total post‐operative complications (OR 1.80, 95% CI 1.12–2.87). Conclusions Pre‐operative infliximab use increased the risk of short‐term post‐operative complications. Subgroup analysis is underpowered to assess the nature of these complications but shows a trend towards increased post‐operative infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Magro, F., Gionchetti, P., Eliakim, R., Ardizzone, S., Armuzzi, A., Barreiro-de Acosta, M., Burisch, J., Gecse, K. B., Hart, A. L., Hindryckx, P., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx008 · Cited by 1,910
Dignass, A., Lindsay, J. O., Sturm, A., Windsor, A., Colombel, J.-F., Allez, M., D'Haens, G., D'Hoore, A., Mantzaris, G., Novacek, G., et al. (2012) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2012.09.002 · Cited by 1,548
Guidelines for the management of inflammatory bowel disease in adults
Mowat, C., Cole, A., Windsor, A., Ahmad, T., Arnott, I., Driscoll, R., Mitton, S., Orchard, T., Rutter, M., Younge, L., et al. (2011) · Gut · doi:10.1136/gut.2010.224154 · Cited by 1,419
Harbord, M., Eliakim, R., Bettenworth, D., Karmiris, K., Katsanos, K., Kopylov, U., Kucharzik, T., Molnár, T., Raine, T., Sebastian, S., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx009 · Cited by 1,180
Watt, D. G., Horgan, P. G., & McMillan, D. C. (2015) · Surgery · doi:10.1016/j.surg.2014.09.009 · Cited by 385
Metadata
- Authors
- YANG, Z., WU, Q., WU, K., & FAN, D.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2010-01-12
- Volume
- 31
- Issue
- 4
- Pages
- 486-492
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2156134689
- Cited by
- 138
- References
- 0
- FWCI
- 7.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Meta‐analysis: pre‐operative infliximab treatment and short‐term post‐operative complications in patients with ulcerative colitis. https://app.cochat.ai/papers/10.1111/j.1365-2036.2009.04204.x
- The paper
- YANG, Z., WU, Q., WU, K., & FAN, D. (2010). Meta‐analysis: pre‐operative infliximab treatment and short‐term post‐operative complications in patients with ulcerative colitis. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2009.04204.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.